Blood tests and score to predict survival in ICU sepsis patients
Part of Immune system & allergy clinical trials.
This study looks at whether simple blood tests and a bedside score can help predict who is more likely to die from sepsis in the ICU. It does not involve any experimental drug or treatment—it just tracks existing lab results and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be in the ICU with a confirmed sepsis diagnosis (based on current medical guidelines)
- Your baseline lab results (like blood tests) must be available
- You cannot have blood cancers (such as leukemia or lymphoma) or be on active chemotherapy
- You must not be on chronic immunosuppressive therapy (like after transplant or high-dose steroids)
- You cannot be pregnant or breastfeeding, and you ICU stay must be at least 24 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study is testing two different simple blood tests to see which one better predicts sepsis (a severe infection response) and outcomes in ICU patients after surgery or trauma. It aims to help doctors identify high-risk patients sooner and improve care.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
Hear when a new Inflamatory Markers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.